Plinabulin
(3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione
Molecular Identity
Plinabulin
(3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione
PubChem CID: 9949641
Plinabulin is a member of the class of 2,5-diketopiperazines that is piperazine-2,5-dione substituted by benzylidene and (5-tert-butyl-1H-imidazol-4-yl)methylidene groups at positions 3 and 6, respectively. It is a vascular disrupting agent and a microtubule destabalising agent which was in clinical trials (now discontinued) for the treatment of non-small cell lung cancer. It has a role as an antineoplastic agent, an angiogenesis inhibitor, a microtubule-destabilising agent and an apoptosis inducer. It is a member of benzenes, a member of imidazoles, a member of 2,5-diketopiperazines and an olefinic compound.
2D Structure
Properties
C19H20N4O2
Molecular Formula
336.40
Molecular Weight
g/mol
336.1586
Exact Mass
Da
2.8
XLogP
Drug-like (Lipinski: < 5)
86.9
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
3
H-Bond Acceptors
597
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Plinabulin714272-27-2NPI-2358plinabulinaplinabulineNPI 2358plinabulinum986FY7F8XRNPI2358CHEBI:177413DTXSID2010313112,5-Piperazinedione, 3-((5-(1,1-dimethylethyl)-1H-imidazol-4-yl)methylene)-6-(phenylmethylene)-, (3Z,6Z)-RefChem:863841DTXCID101516316(3Z,6Z)-3-((5-tert-butyl-1H-imidazol-4-yl)methylidene)-6-(phenylmethylidene)piperazine-2,5-dione
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Plinabulin
Loading drug network...